These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 2908303

  • 21. Influence of carvedilol and propranolol on coronary blood flow.
    Sievert H, Frey G, Schräder R, Schmidt T, van der Does R, Kaltenbach M, Kober G.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816
    [Abstract] [Full Text] [Related]

  • 23. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
    Nakahara H, Nakazawa M, Takeda K, Imai S.
    Jpn J Pharmacol; 1985 Dec 26; 39(4):487-92. PubMed ID: 2419613
    [Abstract] [Full Text] [Related]

  • 24. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Hypertens; 1984 Oct 26; 2(5):529-34. PubMed ID: 6152280
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL, McLean K, Meredith PA, Sumner DJ, Reid JL.
    Br J Clin Pharmacol; 1984 May 26; 17(5):565-72. PubMed ID: 6145440
    [Abstract] [Full Text] [Related]

  • 29. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G, Sampieri L, Cuspidi C, Boselli L, Terzoli L, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1987 May 26; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [Abstract] [Full Text] [Related]

  • 30. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H, Kanda A, Hubo H, Tanaka M.
    J Cardiovasc Pharmacol; 1991 May 26; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA, Prichard BN, Boakes AJ, Tuckman J, Knight EJ.
    Br Heart J; 1977 Jan 26; 39(1):99-106. PubMed ID: 12778
    [Abstract] [Full Text] [Related]

  • 33. Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
    Noguchi K, Kato T, Kinjo N, Moromizato H, Sakanashi M.
    Jpn J Pharmacol; 1990 Jul 26; 53(3):381-91. PubMed ID: 1697348
    [Abstract] [Full Text] [Related]

  • 34. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.
    Pandhi P, Sharma PL, Sharma BK, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1986 May 26; 24(5):249-53. PubMed ID: 3525424
    [Abstract] [Full Text] [Related]

  • 35. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T.
    Clin Investig; 1992 May 26; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [Abstract] [Full Text] [Related]

  • 36. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May 26; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 37. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1987 May 26; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [Abstract] [Full Text] [Related]

  • 38. Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
    Nakagawa Y, Nakahara H, Chin WP, Imai S.
    Jpn J Pharmacol; 1985 Dec 26; 39(4):481-5. PubMed ID: 2419612
    [Abstract] [Full Text] [Related]

  • 39. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug 26; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 40. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M, Takasuna K, Tamura K, Yamaguchi K, Maekawa K, Yamada S, Iwasaki S, Yoshida M, Nomura M, Taguchi K.
    Arzneimittelforschung; 1990 Jul 26; 40(7):735-46. PubMed ID: 1977393
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.